Objectives: To determine the antimicrobial susceptibility of Neisseria gonorrhoeae from Shanghai and to type the quinolone resistance-determining regions (QRDRs) of ciprofloxacin-resistant isolates.
Introduction
The inexorable development of resistance by Neisseria gonorrhoeae isolates to antibiotics has constrained the number of antibiotics that are clinically effective and relevant. The ineffective or inadequate treatment of gonococcal infections inevitably contributes to gonococcal disease complications disproportionately affecting women and their reproductive health, as well as to the further transmission of gonococcal infections. 1 Gonococcal resistance to antimicrobial agents is produced by several mechanisms. Plasmid-mediated resistance may confer resistance to penicillin (i.e. penicillinase-producing N. gonorrhoeae, PPNG) or to tetracycline (i.e. tetracycline-resistant N. gonorrhoeae, TRNG), while chromosomally mediated (CM) resistance is caused by chromosomal mutations at various loci. The accumulation of chromosomal mutations may confer resistance to multiple antibiotics or confer higher levels of resistance to single antibiotics. Quinolone-resistant N. gonorrhoeae (QRNG) isolates are now prevalent in many countries including China. [2] [3] [4] This resistance is primarily caused by point mutations in gyrA and parC at loci described as quinolone resistance-determining regions (QRDRs). 5, 6 Specific mutations in QRDRs in N. gonorrhoeae isolated from Shanghai have not previously been determined. In the present study, we investigated the antimicrobial susceptibility and the molecular mechanisms of quinolone resistance of N. gonorrhoeae isolates from Shanghai.
Materials and methods

Isolation, identification and growth of N. gonorrhoeae isolates
Clinical N. gonorrhoeae isolates (n = 159) were consecutively collected from male patients at the Shanghai Skin Disease and STD Hospital between November 2004 and May 2005. Urogenital specimens were collected using sterile Dacron swabs, which were streaked onto Thayer-Martin (T-M) medium (Oxoid; distributed by GuangZhou LOSO Science Ltd, Shanghai, China) supplemented with 1% IsoVitalex (Oxoid; GuangZhou LOSO Science Ltd). Inoculated T-M plates were incubated at 35 C in a humid, 5% CO 2 environment, for 24-48 h. N. gonorrhoeae was identified using criteria including the oxidase test, Gram stain and glucose utilization tests.
2 Isolates were subcultured on GC agar base (Oxoid; GuangZhou LOSO Science Ltd) supplemented with 1% IsoVitalex (GCBI) prior to antimicrobial susceptibility testing. Isolates were stored at -80 C in brain heart infusion medium (Difco; distributed by Shanghai Chemical Reagent Co., China National Medicine Group, Shanghai, China) containing 20% glycerol. porB DNA sequence analysis of the 159 isolates was performed and indicated that the isolates were not derived from a single clone (data not shown).
Antimicrobial susceptibility testing
The MICs for N. gonorrhoeae of penicillin (0.008-64.0 mg/L), tetracycline (0.008-64.0 mg/L), ciprofloxacin (0.002-64.0 mg/L), spectinomycin (2.0-256.0 mg/L) and ceftriaxone (0.002-2.0 mg/L) were determined by the agar dilution method.
7 Antimicrobial agents were purchased from the Shanghai ANPEL Scientific Instrument Co. Ltd (Shanghai, China; distributors of Sigma-Aldrich, USA). Each MIC determination was performed in duplicate and included WHO reference strains A, B, C, D and E for each test. 8 Gonococcal inocula were prepared by suspending an overnight GCBI culture in 0.9% saline to a turbidity equivalent to that of a 0.5 McFarland standard (Remel, Lenexa KS, USA). The inoculum was adjusted to a final concentration of 10 7 cfu/mL, and 2 mL was delivered onto antibiotic-containing and control GCBI plates using a multispot inoculator (A400 Denley, UK). Inoculated plates were incubated, as described above, for 18-24 h. b-Lactamase production was determined for all isolates using the chromogenic cephalosporin test (Oxoid; GuangZhou LOSO Science Ltd). Interpretative MIC criteria 
QRDR sequence analysis
The DNA sequences of the QRDRs of 103 isolates, comprising 101 ciprofloxacin-resistant isolates, 1 intermediate isolate and 1 susceptible isolate, were determined. These isolates were selected based on their resistance phenotypes and there was no significant difference (P > 0.05) in the resistance classification percentage (i.e. %PPNG, %CMTR, etc.) between these isolates and the 159 original isolates tested. Gonococcal DNA was extracted using the Genomic DNA Purification Kit (Shanghai Promega Biological Products Ltd, Shanghai, China). The QRDRs of gyrA and parC were amplified using PCR (Perkin Elmer 9600 Thermo Cycler; Perkin Elmer, Wellesley, MA USA) as described previously. 5, 6 Primers 5,6 were purchased from Invitrogen Canada (Burlington, Ontario, Canada). Following the purification of PCR products (PCR Purification Kit; Qiagen, Mississauga, Ontario, Canada) their DNA sequences were determined (Plant Biotechnology Institute, National Research Council of Canada, Saskatoon, Canada) using the same primers. 5, 6 DNA sequences were translated using Proteomics and Sequence Tools (http://ca.expasy.org/, last accessed on 25 June 2006). QRDRs from N. gonorrhoeae FA1090 were used as prototypes (GenBank #P48371 for gyrA and #U08907 for parC). Correlation coefficients between QRDR mutations and ciprofloxacin MICs were determined using the F-test (Microsoft Excel).
Results
The antimicrobial susceptibilities of 159 N. gonorrhoeae isolates are summarized in Table 1 Table 2 . The single ciprofloxacin-susceptible isolate tested did not carry mutations in its QRDR of gyrA or parC (mutation pattern P0), while the ciprofloxacin-intermediate isolate carried an Asp-95!Ala mutation in gyrA and a Ser87!Asn mutation in parC (pattern P1). All ciprofloxacin-resistant isolates carried a Ser-91!Phe mutation in the QRDR of gyrA, and some isolates also contained Ala-92!Pro (3/103, 2.9%) and Asp-95!Ala/Gly (85/103, 82.5%) mutations. Single, double or triple mutations in gyrA accounted for 15.5%, 82.5% and 1.0% of mutations in gyrA, respectively. parC mutations occurred in 74.8% of the isolates tested at residues Ser-87 and Glu-91 including Ser-87!Arg (45/ 103, 43.7%) or Ser-87!Asn/Ile/Cys (27/103, 26.2%). Single substitutions at Ser-87 were more commonly found in isolates with parC mutations (69/103, 67.0%), while mutations at Glu-91 accounted for 7.8% of the isolates (8/103). Mutations in gyrA were not correlated with ciprofloxacin MIC values, whereas a significant correlation (P < 0.001) between parC mutation rates and MIC values of ciprofloxacin was observed (data not shown). Mutations in QRDRs were grouped into 19 patterns ( Table 2) . The most predominant patterns, accounting for 65.0% of the 103 isolates tested, included P3, P8, P9 and P15, with mutations at Ser-91 and Asp-95 of gyrA and a single or no mutation at Ser-87 of parC. Isolates with patterns P2, P3, P4 and P16 (24.3%) contained gyrA but no parC mutations. Other patterns were characterized by one substitution in both gyrA and parC (P1, P5 and P6), two mutations in gyrA and one mutation in parC (P7, P8, P9, P10, P11, P14, P15 and P17), double mutations in both gyrA and parC (P12 and P13), three gyrA mutations and one parC mutation (P18) or one gyrA mutation and two parC mutations (P19).
Discussion
The burden of antimicrobial resistance of N. gonorrhoeae isolates has increased in China since the mid-1990s; 8 between 1993 and 1998, 66.7% of 3186 isolates tested were resistant to penicillin and 92.0% were resistant to tetracycline. Ciprofloxacin resistance increased from 15.5% of isolates tested in 1993 to 55.8% in 1998. By 2004 ciprofloxacin-resistant isolates comprised 94.3% (n = 1203) of isolates tested. 9 In comparison, in the present study, the percentage of ciprofloxacin-resistant isolates included over 98% of the isolates, the total burden of penicillin resistance was over 90%, while the burden of tetracycline resistance was 56.5% of the isolates. The percentage of either PPNG or TRNG is consistent with other reports from China in which PPNG comprised 48.8% of 1002 isolates and TRNG included 34.2% of 1202 isolates 9 as compared with 51.6% of isolates typed as being PPNG (and PP/TRNG) and 20.1% characterized as TRNG (and PP/TRNG) in the present study.
The unremitting development of resistance to multiple antibiotics in N. gonorrhoeae isolates has provoked the ongoing modification of treatment guidelines in China; the recommended treatment of choice for uncomplicated gonococcal infections changed from penicillin, in 1989, to ciprofloxacin in 1995, and subsequently to ceftriaxone or spectinomycin in 2000 (Diagnostic criteria and management of gonorrhoea, Ministry of Health, People's Republic of China, 2000). Although none of the circulating isolates tested in the present study was resistant to either spectinomycin or ceftriaxone, a small percentage was characterized as having intermediate levels of susceptibility to spectinomycin. Importantly, the MIC 90 of ceftriaxone was one dilution lower than the concentration defining the limits of susceptibility 7 and over 10% of the isolates had MICs which were within two dilutions of this critical concentration. Other reports from China have also documented isolates with decreased susceptibility to ceftriaxone. 8, 9 The majority of the QRDR mutation patterns included double mutations of gyrA (Ser-91!Phe and Asp-95!Ala/Gly) combined with a single (Ser-87!Arg/Asn) or no mutation of parC ( Table 2) . Although these and other mutation patterns have also been observed by other investigators from different countries, 10, 11 the predominant mutational patterns varied from those reported in other regions. The presence of parC mutations was significantly associated with higher ciprofloxacin MIC values, suggesting that parC mutations proportionately reduce susceptibility and enhance resistance to quinolones in N. gonorrhoeae isolates. The absence of parC mutations in some ciprofloxacin-resistant isolates indicates that it is not always the primary determinant specifying gonococcal resistance to ciprofloxacin. gyrA mutations were present in all ciprofloxacin-resistant isolates but not in the one ciprofloxacin-susceptible isolate, indicating that gyrA mutations are necessary for the quinolone resistance phenotype. Thus, the present study quantitatively supports the hypothesis that gyrA mutations determine whether a gonococcal isolate is resistant to quinolones, while a mutation in parC is correlated with high-level quinolone resistance.
11
The study combines antimicrobial susceptibility determinations with molecular-based analysis of ciprofloxacin resistance in N. gonorrhoeae isolated in Shanghai. While ceftriaxone and spectinomycin should be effective antibiotics for the treatment of gonorrhoea in Shanghai, continued monitoring of gonococcal susceptibility to these agents is crucial given the decreased susceptibilities of some isolates. The identification of ciprofloxacin-resistant isolates coupled with the characterization of QRDR mutation patterns will serve as a baseline to better appreciate gonococcal transmission patterns and the evolution of resistant clones in Shanghai. 
